Literature DB >> 23759319

Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques.

Carlos Barcia1, Carmen María Ros, Francisco Ros-Bernal, Aurora Gómez, Valentina Annese, María Angeles Carrillo-de Sauvage, José Enrique Yuste, Carmen María Campuzano, Vicente de Pablos, Emiliano Fernández-Villalba, María Trinidad Herrero.   

Abstract

Patients with Parkinson's disease show persistent microglial activation in the areas of the brain where the degeneration of dopaminergic neurons takes place. The reason for maintaining this activated state is still unknown, but it is thought that this persistent microglial activation may contribute to the degeneration of dopaminergic neurons. In this study, we report the microanatomical details of microglia and the relationship between microglia and neurons in the substantia nigra pars compacta of Parkinsonian monkeys years after insult with MPTP. We observed that microglial cells appear polarized toward dopaminergic neurons in MPTP-treated macaques compared to untreated animals and present clear phagocytic characteristics, such as engulfing gliaptic contacts, an increase in Golgi apparatus protein machinery and ball-and-chain phagocytic buds. These results demonstrate that activated microglia maintain phagocytic characteristics years after neurotoxin insult, and phagocytosis may be a key contributor to the neurodegenerative process.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine; 4′,6-diamidino-2-phenylindole; Cell polarity; DAPI; Dopaminergic degeneration; GM130; Iba-1; Inflammation; MPTP; Microglial motility; PD; Parkinson's disease; SNpc; TH; cis-Golgi matrix protein 130; ionized calcium binding adaptor molecule 1; substantia nigra pars compacta; tyrosine hydroxylase

Mesh:

Year:  2013        PMID: 23759319     DOI: 10.1016/j.jneuroim.2013.05.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

Review 1.  Microglial phenotypes in Parkinson's disease and animal models of the disease.

Authors:  Valerie Joers; Malú G Tansey; Giovanna Mulas; Anna R Carta
Journal:  Prog Neurobiol       Date:  2016-04-20       Impact factor: 11.685

2.  Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.

Authors:  M Feher; B Gaszner; A Tamas; A L Gil-Martinez; E Fernandez-Villalba; M T Herrero; D Reglodi
Journal:  Neurotox Res       Date:  2017-12-11       Impact factor: 3.911

3.  Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models.

Authors:  Daniela Lecca; Elzbieta Janda; Giovanna Mulas; Andrea Diana; Concetta Martino; Fabrizio Angius; Stefano Spolitu; Maria Antonietta Casu; Gabriella Simbula; Laura Boi; Barbara Batetta; Saturnino Spiga; Anna R Carta
Journal:  Br J Pharmacol       Date:  2018-07-12       Impact factor: 8.739

Review 4.  Contributions of Nonhuman Primates to Research on Aging.

Authors:  E S Didier; A G MacLean; M Mohan; P J Didier; A A Lackner; M J Kuroda
Journal:  Vet Pathol       Date:  2016-02-11       Impact factor: 2.221

5.  Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.

Authors:  Maria Nikodemova; Alissa L Small; Rebecca S Kimyon; Jyoti J Watters
Journal:  Physiol Genomics       Date:  2016-02-16       Impact factor: 3.107

Review 6.  Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

Authors:  Fillipe M de Araújo; Lorena Cuenca-Bermejo; Emiliano Fernández-Villalba; Silvia L Costa; Victor Diogenes A Silva; Maria Trinidad Herrero
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

7.  Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.

Authors:  Nikhil Panicker; Hariharan Saminathan; Huajun Jin; Matthew Neal; Dilshan S Harischandra; Richard Gordon; Kavin Kanthasamy; Vivek Lawana; Souvarish Sarkar; Jie Luo; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

8.  Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.

Authors:  Tcs Costa; E Fernandez-Villalba; V Izura; A M Lucas-Ochoa; N J Menezes-Filho; R C Santana; M D de Oliveira; F M Araújo; C Estrada; Vda Silva; S L Costa; M T Herrero
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-21       Impact factor: 4.147

9.  Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation.

Authors:  Sandra M Rocha; Tatiana Saraiva; Ana C Cristóvão; Raquel Ferreira; Tiago Santos; Marta Esteves; Cláudia Saraiva; Goun Je; Luísa Cortes; Jorge Valero; Gilberto Alves; Alexander Klibanov; Yoon-Seong Kim; Liliana Bernardino
Journal:  J Neuroinflammation       Date:  2016-06-04       Impact factor: 8.322

Review 10.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.

Authors:  Felipe Correa-da-Silva; Eric Fliers; Dick F Swaab; Chun-Xia Yi
Journal:  J Neuroendocrinol       Date:  2021-06-22       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.